Skin Cancer

SKIN CANCER ADVISOR

HEADLINES
TREATMENT REGIMENS
DRUG INFORMATION

FEATURED CONTENT

An Early Study Suggests the Flu Shot Could Someday Be Used as Part of an Immunotherapy Regimen in Cancer

A new study describes how the flu vaccine creates an antitumoral response in mouse models of metastatic melanoma that has spread to the lungs.
PAK4 in Melanoma: Could This Target Extend Immunotherapy’s Reach?

Combining PD-1 blockade with PAK4 inhibitors could boost the number of patients helped by the therapy.
Reporting Mechanisms for Conflict of Interest Disclosures in Medicine Need Standardization

ASCO officials examined the discrepancies in financial disclosures across platforms and call for a simplified system.
Popular Genetic Tests Miss Many Cancer-Associated Genetic Variants, Particularly in Ethnic Minorities

The chance of missing a disease-causing variant can be as high as 100% across some groups.
Immune Checkpoint Inhibitors on Track for Better Personalization

Emerging evidence suggests that a better understanding of T-cell behavior may help immune checkpoint inhibitors become more personalized.

VIDEO SERIES

Recent Advances in Melanoma Therapy

Targeted Treatments and Immunotherapies for Melanoma

Tailoring Treatments in Melanoma

Drug Resistance in Melanoma

Affordability of Melanoma Care

Melanoma: Treatment-induced Toxicity

Immunotherapy: A Decade of Improvements in Melanoma

Should Patients With Melanoma Receive Targeted Therapy or Immunotherapy First?

Melanoma: Checkpoints in the Pipeline

Targeting Therapy for Melanoma Subtypes

Melanoma: Targetable Genes in the Pipeline

Clinical Trials in Melanoma

SKIN CANCER NEWS

In the immunotherapy era, the optimal setting and sequencing of BRAF+MEK inhibition remains unresolv

High Cutaneous Melanoma Burden Found Due to UV Radiation

February 19, 2020

Treatment-naïve patients with advanced melanoma had significantly better clinical outcomes with nivo

Studies Explore Prevalence of Skin Cancer Among Sexual Minorities

February 13, 2020

Smartphone Apps Not Accurate Enough to Detect All Melanomas

February 12, 2020

Approximately 10% to 20% of all cutaneous melanomas arise in the head and neck region. Melanoma of the neck accounts for 29% of cancers in the head and neck region, and melanoma of the scalp makes up 14% of cancers in that area.

Circulating Tumor Cells Predict Relapse in Stage III Melanoma

February 10, 2020

Close up view of melanoma.

Risk Factors Associated With Central Nervous System Metastasis in Stage III Melanoma

February 6, 2020

Next post in Skin Cancer

Treatment-naïve patients with advanced melanoma had significantly better clinical outcomes with nivo

Studies Explore Prevalence of Skin Cancer Among Sexual Minorities